{"study_id": 98103, "supplement_id": 848, "safety_score": "20", "efficacy_score": null, "quality_score": 60, "study_goal": "The researchers aimed to identify and describe dietary supplements, including 1,3-Dimethylamylamine, associated with liver injury (DSILI).", "results_summary": "The study listed 1,3-Dimethylamylamine as a single-ingredient dietary supplement linked to liver injury, but did not provide specific data on its effects.", "population_specificity": "Not specified (general DS consumers with reported liver injury).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:33:47.588314+00:00"}
{"study_id": 1392, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate whether valproate increases central serotonin metabolism in manic patients by examining cortisol responses to L-5-HTP.", "results_summary": "L-5-HTP administration significantly increased cortisol responses before and after valproate treatment, with higher responses post-treatment, suggesting valproate may enhance serotonergic neurotransmission.", "population_specificity": "10 manic patients", "effective_dosage": "200 mg (orally) L-5-HTP", "study_duration": "Subchronic treatment (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:33:47.715796+00:00"}
{"study_id": 1391, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of 5-HT1B and 5-HT1A receptors in 5-HTP's inhibitory effects on male rat ejaculatory behavior.", "results_summary": "5-HTP increased ejaculation latency in male rats, an effect mediated by postsynaptic 5-HT1B receptors and modulated by 5-HT1A autoreceptors. The 5-HT1A antagonist WAY-100635 enhanced 5-HTP's inhibitory effects, while 5-HT2A/C agonist DOI did not affect behavior alone but reduced ejaculation when combined with (-)-pindolol.", "population_specificity": "Male rats", "effective_dosage": "25 mg/kg (intraperitoneal)", "study_duration": "Not specified", "interactions": "Interaction with 5-HT1 receptor antagonist (-)-pindolol and 5-HT1B receptor antagonist isamoltane noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:33:50.216566+00:00"}
{"study_id": 1393, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the diagnostic potential of 11C-5-HTP PET imaging in detecting metastatic lesions in hormone-refractory prostatic adenocarcinoma and assess its utility for treatment monitoring.", "results_summary": "The study found increased uptake of 11C-5-HTP in all skeletal metastatic lesions, with significant differences compared to normal bone (p < 0.001). Uptake kinetics showed initial increase followed by wash-out, suggesting diagnostic utility but not definitive proof of neuroendocrine differentiation.", "population_specificity": "10 patients with metastatic hormone-refractory prostatic adenocarcinoma (3 underwent repeated imaging post-treatment).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:33:56.692934+00:00"}
{"study_id": 1394, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether subchronic and chronic 5-HTP treatment could attenuate aggression and affect dominance behaviors in undernourished dominant pigeons.", "results_summary": "Both subchronic (4-day) and chronic (16-day) 5-HTP treatments reduced aggression and intra-test body weight gain in dominant pigeons without decreasing feeder control dominance. Recovery scores showed aggression returned to baseline after subchronic treatment but remained lower after chronic treatment, suggesting a learned behavioral adaptation.", "population_specificity": "Undernourished adult male pigeons with previously established dominance hierarchies.", "effective_dosage": "7.5 mg/kg, administered subcutaneously 30 minutes before trials.", "study_duration": "4 days (subchronic) and 16 days (chronic).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:33:57.190552+00:00"}
{"study_id": 1395, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of 5-HTP on ethanol consumption and its potential central and peripheral mechanisms of action.", "results_summary": "5-HTP administration reduced ethanol intake initially and persistently, with central actions mediating the initial effects and peripheral actions linked to persistent avoidance. Xylamidine blocked persistent effects but not initial inhibition, while methysergide reduced both.", "population_specificity": "Not specified (likely animal models based on conditioning paradigms).", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "Xylamidine and methysergide were noted to interact with 5-HTP's effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:33:59.281198+00:00"}
{"study_id": 1396, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine how the timing of 5-HTP and L-DOPA administration affects gonadal growth and regression in quail under different photoperiods.", "results_summary": "The study found that 5-HTP and L-DOPA administration stimulated cloacal gland growth under intermediate day length and slowed regression under short days, suggesting these drugs can reset endogenous mechanisms controlling seasonality.", "population_specificity": "Sexually immature Japanese quail raised under short photoperiod (LD8:16).", "effective_dosage": "Not specified", "study_duration": "11 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:34:04.750585+00:00"}
{"study_id": 1397, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether 5-HTP could reverse insomnia induced by serotonin synthesis inhibition (p-CPA) in rats and whether this effect was mediated by central 5-HTP action.", "results_summary": "The study found that 5-HTP transiently reversed p-CPA-induced insomnia in rats, but no detectable increase in cerebral serotonin was observed, suggesting the effect may be mediated by 5-HTP itself rather than serotonin conversion.", "population_specificity": "Rats (animal model)", "effective_dosage": "Not specified", "study_duration": "Transient (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:34:05.183457+00:00"}
{"study_id": 1398, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of L-dopa and benserazide on serotonin metabolism, specifically measuring changes in 5-HTP, 5-HT, and 5-HIAA levels in rat brain areas.", "results_summary": "5-HTP levels increased rapidly, peaking at 1.5 hours before returning to baseline within 4 hours, while 5-HT levels significantly decreased without changes in 5-HIAA, suggesting L-dopa interferes with serotonin synthesis.", "population_specificity": "Rats (hypothalamus, hippocampus, striatum, and olfactory bulbs)", "effective_dosage": "L-dopa (125 mg/kg, ip) + benserazide (50 mg/kg, ip)", "study_duration": "Single-dose intervention with measurements up to 4 hours", "interactions": "L-dopa and benserazide (competitive inhibition of aromatic amino acid decarboxylase)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:34:09.037543+00:00"}
{"study_id": 1399, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether 5-HTP administration leads to the formation and release of serotonin as a \"false transmitter\" in striatal dopamine neurons.", "results_summary": "The study found that 5-HTP administration caused dose-dependent serotonin release in striatal dopamine neurons, even when dopamine release was not fully abolished, suggesting 5-HT acts as a false transmitter in these neurons. Voltammetric analysis confirmed simultaneous dopamine and serotonin release from the same nerves.", "population_specificity": "Rats", "effective_dosage": "Dose-dependent (specific amounts not stated)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:34:12.875793+00:00"}
{"study_id": 1401, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine how 5-HT depletion methods (including 5-HTP) affect nociception and the antinociceptive effects of 5-HT agonists in mice.", "results_summary": "5-HTP showed enhanced antinociceptive effects in 5,7-DHT-lesioned mice in both tail-flick and hot-plate tests, but other 5-HT depleting agents (PCPA, PCA) did not significantly alter its efficacy. The study suggests 5,7-DHT may induce post-synaptic 5-HT receptor supersensitivity.", "population_specificity": "Mice with induced 5-HT depletion.", "effective_dosage": "Not specified for 5-HTP (other agents: 5,7-DHT 80 \u00b5g, PCA 3-4 x 40 mg/kg, PCPA 5-14 x 400 mg/kg).", "study_duration": "Effects observed at 2, 5, and 8 days post-treatment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:34:15.716339+00:00"}
{"study_id": 1402, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to determine how 5-HTP interacts with opioid receptors and affects feeding behavior in rats, particularly when combined with subeffective doses of opioids or naloxone.", "results_summary": "The study found that subeffective doses of 5-HTP, when combined with subcutaneous morphine or naloxone, induced anorexia in food-deprived rats, but this effect was not observed with intraventricular administration. The results suggest that opioid-serotonergic interactions influencing feeding behavior may occur preferentially in the periphery.", "population_specificity": "Food-deprived rats", "effective_dosage": "Subeffective doses (specific amounts not provided)", "study_duration": "Not specified", "interactions": "Interaction noted with morphine and naloxone when administered subcutaneously, but not intraventricularly.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:34:17.927647+00:00"}
{"study_id": 1403, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 60, "study_goal": "The researchers aimed to determine the short-term effects of 5-HTP on the lymphokine system and its potential role in sleep promotion.", "results_summary": "Ten minutes after 5-HTP treatment, a decrease was observed in most tested parameters (except IL-3 and CSF secretion), indicating a transient suppressive effect on immune function. The study noted 5-HTP had relatively weak potency compared to DSIP.", "population_specificity": "Not specified (likely animal or in vitro model based on abstract).", "effective_dosage": "Not mentioned", "study_duration": "Short-term (effects measured at 10 and 30 minutes post-treatment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:34:21.849787+00:00"}
{"study_id": 1404, "supplement_id": 850, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether L-5-HTP could effectively treat recurring headaches and sleep disorders in children with depressive symptoms and attentional-memory deficiencies.", "results_summary": "The study found that L-5-HTP was effective in reducing headaches and some sleep disorders, particularly frequent awakenings and parasomnias, as confirmed by a double-blind, crossover trial with placebo.", "population_specificity": "Elementary and junior high school students with recurring headaches, sleep disorders, and depressive symptoms but normal intellectual capacity.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-17T23:34:23.602636+00:00"}
